MCL coexpression mm9:797
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr11:79153143..79153195,+ | p1@Nf1 |
Mm9::chr15:99125642..99125710,+ | p1@Prpf40b |
Mm9::chr16:90284545..90284593,- | p2@Scaf4 |
Mm9::chr2:32986085..32986140,- | p1@Garnl3 |
Mm9::chr3:94386470..94386495,- | p1@Snx27 |
Mm9::chr5:23181745..23181756,- | p5@Srpk2 |
Mm9::chr5:23181759..23181815,- | p2@Srpk2 |
Mm9::chr5:54200871..54200922,+ | p1@Tbc1d19 |
Mm9::chr8:108020923..108020968,- | p1@Zdhhc1 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0046929 | negative regulation of neurotransmitter secretion | 0.0122811985351359 |
GO:0021897 | forebrain astrocyte development | 0.0122811985351359 |
GO:0021896 | forebrain astrocyte differentiation | 0.0122811985351359 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 0.0122811985351359 |
GO:0022011 | myelination in the peripheral nervous system | 0.0122811985351359 |
GO:0048712 | negative regulation of astrocyte differentiation | 0.0122811985351359 |
GO:0032292 | ensheathment of axons in the peripheral nervous system | 0.0122811985351359 |
GO:0005096 | GTPase activator activity | 0.0122811985351359 |
GO:0014065 | phosphoinositide 3-kinase cascade | 0.0122811985351359 |
GO:0046580 | negative regulation of Ras protein signal transduction | 0.0122811985351359 |
GO:0001937 | negative regulation of endothelial cell proliferation | 0.0122811985351359 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 0.0122811985351359 |
GO:0035021 | negative regulation of Rac protein signal transduction | 0.0122811985351359 |
GO:0048485 | sympathetic nervous system development | 0.0122811985351359 |
GO:0001953 | negative regulation of cell-matrix adhesion | 0.0122811985351359 |
GO:0014002 | astrocyte development | 0.0122811985351359 |
GO:0014044 | Schwann cell development | 0.0122811985351359 |
GO:0048853 | forebrain morphogenesis | 0.0122811985351359 |
GO:0032320 | positive regulation of Ras GTPase activity | 0.0122811985351359 |
GO:0008380 | RNA splicing | 0.0122811985351359 |
GO:0043525 | positive regulation of neuron apoptosis | 0.0122811985351359 |
GO:0048710 | regulation of astrocyte differentiation | 0.0122811985351359 |
GO:0001938 | positive regulation of endothelial cell proliferation | 0.0122811985351359 |
GO:0051224 | negative regulation of protein transport | 0.0122811985351359 |
GO:0048713 | regulation of oligodendrocyte differentiation | 0.0122811985351359 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 0.0122811985351359 |
GO:0048854 | brain morphogenesis | 0.0122811985351359 |
GO:0042308 | negative regulation of protein import into nucleus | 0.0122811985351359 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 0.0122811985351359 |
GO:0051932 | synaptic transmission, GABAergic | 0.0122811985351359 |
GO:0032228 | regulation of synaptic transmission, GABAergic | 0.0122811985351359 |
GO:0048745 | smooth muscle development | 0.0122811985351359 |
GO:0022408 | negative regulation of cell-cell adhesion | 0.0122811985351359 |
GO:0008047 | enzyme activator activity | 0.0129742049098401 |
GO:0048844 | artery morphogenesis | 0.0132127414522 |
GO:0043409 | negative regulation of MAPKKK cascade | 0.0132127414522 |
GO:0007243 | protein kinase cascade | 0.0132127414522 |
GO:0007242 | intracellular signaling cascade | 0.0132127414522 |
GO:0006397 | mRNA processing | 0.0132127414522 |
GO:0014014 | negative regulation of gliogenesis | 0.0132127414522 |
GO:0045686 | negative regulation of glial cell differentiation | 0.0132127414522 |
GO:0001936 | regulation of endothelial cell proliferation | 0.0132127414522 |
GO:0007406 | negative regulation of neuroblast proliferation | 0.0132127414522 |
GO:0035020 | regulation of Rac protein signal transduction | 0.0132127414522 |
GO:0045124 | regulation of bone resorption | 0.0132127414522 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 0.0132127414522 |
GO:0016071 | mRNA metabolic process | 0.0139020802348034 |
GO:0048708 | astrocyte differentiation | 0.0139020802348034 |
GO:0048483 | autonomic nervous system development | 0.0139020802348034 |
GO:0001952 | regulation of cell-matrix adhesion | 0.0139020802348034 |
GO:0014037 | Schwann cell differentiation | 0.0139020802348034 |
GO:0021987 | cerebral cortex development | 0.0139430757270679 |
GO:0042990 | regulation of transcription factor import into nucleus | 0.0139430757270679 |
GO:0045671 | negative regulation of osteoclast differentiation | 0.0139430757270679 |
GO:0042991 | transcription factor import into nucleus | 0.0139430757270679 |
GO:0018345 | protein palmitoylation | 0.0139430757270679 |
GO:0001935 | endothelial cell proliferation | 0.0139430757270679 |
GO:0042306 | regulation of protein import into nucleus | 0.0139430757270679 |
GO:0045685 | regulation of glial cell differentiation | 0.0139430757270679 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 0.0139430757270679 |
GO:0014013 | regulation of gliogenesis | 0.0139430757270679 |
GO:0022407 | regulation of cell-cell adhesion | 0.0139430757270679 |
GO:0033157 | regulation of intracellular protein transport | 0.0139430757270679 |
GO:0030325 | adrenal gland development | 0.0139430757270679 |
GO:0032386 | regulation of intracellular transport | 0.0139430757270679 |
GO:0030695 | GTPase regulator activity | 0.0139430757270679 |
GO:0021782 | glial cell development | 0.0148901900249385 |
GO:0048709 | oligodendrocyte differentiation | 0.0148901900249385 |
GO:0051223 | regulation of protein transport | 0.0159094881213838 |
GO:0048169 | regulation of long-term neuronal synaptic plasticity | 0.0159094881213838 |
GO:0009966 | regulation of signal transduction | 0.0164158545922221 |
GO:0007264 | small GTPase mediated signal transduction | 0.0164158545922221 |
GO:0046822 | regulation of nucleocytoplasmic transport | 0.0164158545922221 |
GO:0051048 | negative regulation of secretion | 0.0164158545922221 |
GO:0006396 | RNA processing | 0.0164482517415702 |
GO:0051349 | positive regulation of lyase activity | 0.0164482517415702 |
GO:0045762 | positive regulation of adenylate cyclase activity | 0.0164482517415702 |
GO:0007162 | negative regulation of cell adhesion | 0.0164482517415702 |
GO:0031281 | positive regulation of cyclase activity | 0.0164482517415702 |
GO:0021510 | spinal cord development | 0.0164482517415702 |
GO:0021543 | pallium development | 0.0170713839836996 |
GO:0030336 | negative regulation of cell migration | 0.0170713839836996 |
GO:0048168 | regulation of neuronal synaptic plasticity | 0.0170713839836996 |
GO:0045453 | bone resorption | 0.0172496299708533 |
GO:0045670 | regulation of osteoclast differentiation | 0.0172496299708533 |
GO:0016601 | Rac protein signal transduction | 0.0172496299708533 |
GO:0016409 | palmitoyltransferase activity | 0.0172496299708533 |
GO:0030199 | collagen fibril organization | 0.0172496299708533 |
GO:0016525 | negative regulation of angiogenesis | 0.0179887538148397 |
GO:0045761 | regulation of adenylate cyclase activity | 0.0179887538148397 |
GO:0043407 | negative regulation of MAP kinase activity | 0.018393557445004 |
GO:0031279 | regulation of cyclase activity | 0.018393557445004 |
GO:0048593 | camera-type eye morphogenesis | 0.018393557445004 |
GO:0051051 | negative regulation of transport | 0.018393557445004 |
GO:0043408 | regulation of MAPKKK cascade | 0.018393557445004 |
GO:0051339 | regulation of lyase activity | 0.018393557445004 |
GO:0051271 | negative regulation of cell motility | 0.018393557445004 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 0.018393557445004 |
GO:0046928 | regulation of neurotransmitter secretion | 0.018393557445004 |
GO:0040013 | negative regulation of locomotion | 0.0190288725956882 |
GO:0045638 | negative regulation of myeloid cell differentiation | 0.0190288725956882 |
GO:0030316 | osteoclast differentiation | 0.0192652183901487 |
GO:0050768 | negative regulation of neurogenesis | 0.0192652183901487 |
GO:0050804 | regulation of synaptic transmission | 0.0192652183901487 |
GO:0051969 | regulation of transmission of nerve impulse | 0.0192652183901487 |
GO:0001666 | response to hypoxia | 0.019484014560574 |
GO:0001889 | liver development | 0.019484014560574 |
GO:0048167 | regulation of synaptic plasticity | 0.019484014560574 |
GO:0000245 | spliceosome assembly | 0.019484014560574 |
GO:0043543 | protein amino acid acylation | 0.0198629027162399 |
GO:0007632 | visual behavior | 0.0198629027162399 |
GO:0008542 | visual learning | 0.0198629027162399 |
GO:0007422 | peripheral nervous system development | 0.0202218303126749 |
GO:0021537 | telencephalon development | 0.0202218303126749 |
GO:0050803 | regulation of synapse structure and activity | 0.0202218303126749 |
GO:0007270 | nerve-nerve synaptic transmission | 0.0209168425513918 |
GO:0001894 | tissue homeostasis | 0.0215997851100231 |
GO:0007405 | neuroblast proliferation | 0.0218997821277769 |
GO:0031644 | regulation of neurological process | 0.0218997821277769 |
GO:0048871 | multicellular organismal homeostasis | 0.0218997821277769 |
GO:0042552 | myelination | 0.0223668092785619 |
GO:0001649 | osteoblast differentiation | 0.0223668092785619 |
GO:0007272 | ensheathment of neurons | 0.0234419050993873 |
GO:0046850 | regulation of bone remodeling | 0.0234419050993873 |
GO:0008366 | axon ensheathment | 0.0234419050993873 |
GO:0045765 | regulation of angiogenesis | 0.0240551482023171 |
GO:0032318 | regulation of Ras GTPase activity | 0.0262436823525306 |
GO:0043523 | regulation of neuron apoptosis | 0.0268247639975477 |
GO:0045637 | regulation of myeloid cell differentiation | 0.0273966653713882 |
GO:0006469 | negative regulation of protein kinase activity | 0.0277461663059406 |
GO:0033673 | negative regulation of kinase activity | 0.0277461663059406 |
GO:0001508 | regulation of action potential | 0.028297754960841 |
GO:0051402 | neuron apoptosis | 0.0284136106874411 |
GO:0051348 | negative regulation of transferase activity | 0.0284136106874411 |
GO:0010001 | glial cell differentiation | 0.0284136106874411 |
GO:0002573 | myeloid leukocyte differentiation | 0.0295521882743893 |
GO:0042063 | gliogenesis | 0.0295521882743893 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 0.0295521882743893 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 0.0295521882743893 |
GO:0000375 | RNA splicing, via transesterification reactions | 0.0295521882743893 |
GO:0048592 | eye morphogenesis | 0.0307672006968334 |
GO:0006497 | protein amino acid lipidation | 0.0312575822387891 |
GO:0050767 | regulation of neurogenesis | 0.0313031448429776 |
GO:0030155 | regulation of cell adhesion | 0.0313031448429776 |
GO:0001656 | metanephros development | 0.0313031448429776 |
GO:0008017 | microtubule binding | 0.031776118320949 |
GO:0043086 | negative regulation of catalytic activity | 0.0320246520231212 |
GO:0042158 | lipoprotein biosynthetic process | 0.0320246520231212 |
GO:0035270 | endocrine system development | 0.0324829642923157 |
GO:0007612 | learning | 0.0329350187926033 |
GO:0007269 | neurotransmitter secretion | 0.0340448277463405 |
GO:0030334 | regulation of cell migration | 0.0342548629309296 |
GO:0051046 | regulation of secretion | 0.0342548629309296 |
GO:0015631 | tubulin binding | 0.0357518516228022 |
GO:0007188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 0.0357518516228022 |
GO:0006606 | protein import into nucleus | 0.0358861806290778 |
GO:0035023 | regulation of Rho protein signal transduction | 0.0358861806290778 |
GO:0030198 | extracellular matrix organization and biogenesis | 0.0358861806290778 |
GO:0051170 | nuclear import | 0.0358861806290778 |
GO:0042157 | lipoprotein metabolic process | 0.0358861806290778 |
GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 0.0362849803491617 |
GO:0051270 | regulation of cell motility | 0.0366787207857105 |
GO:0043405 | regulation of MAP kinase activity | 0.0368414737651879 |
GO:0019933 | cAMP-mediated signaling | 0.0368414737651879 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 0.03789398518955 |
GO:0007160 | cell-matrix adhesion | 0.03789398518955 |
GO:0040012 | regulation of locomotion | 0.03789398518955 |
GO:0045055 | regulated secretory pathway | 0.03789398518955 |
GO:0043087 | regulation of GTPase activity | 0.03789398518955 |
GO:0017038 | protein import | 0.03789398518955 |
GO:0021915 | neural tube development | 0.0382568214182381 |
GO:0031589 | cell-substrate adhesion | 0.0391960958687573 |
GO:0007611 | learning and/or memory | 0.0395468297299959 |
GO:0022618 | protein-RNA complex assembly | 0.0404671364940083 |
GO:0001822 | kidney development | 0.0417081668276912 |
GO:0009416 | response to light stimulus | 0.0417081668276912 |
GO:0048732 | gland development | 0.0420360376301079 |
GO:0043010 | camera-type eye development | 0.042360101196051 |
GO:0001655 | urogenital system development | 0.0441042001662615 |
GO:0042060 | wound healing | 0.0441042001662615 |
GO:0007266 | Rho protein signal transduction | 0.0444108602440817 |
GO:0051049 | regulation of transport | 0.0463548636800031 |
GO:0045596 | negative regulation of cell differentiation | 0.0466452747343961 |
GO:0003001 | generation of a signal involved in cell-cell signaling | 0.0474729333330186 |
GO:0001505 | regulation of neurotransmitter levels | 0.0477538060040931 |
GO:0009968 | negative regulation of signal transduction | 0.0485658988273496 |
GO:0030099 | myeloid cell differentiation | 0.0488549614305601 |
GO:0006913 | nucleocytoplasmic transport | 0.0488549614305601 |
GO:0009314 | response to radiation | 0.0488549614305601 |
GO:0001503 | ossification | 0.0488549614305601 |
GO:0051169 | nuclear transport | 0.0488549614305601 |
GO:0031214 | biomineral formation | 0.0491177119273748 |
GO:0007519 | skeletal muscle development | 0.049377626283681 |
Relative expression of the co-expression cluster over median <br>Analyst:
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |